Study the effectiveness of concomitant use of vitamin C, metformin, azithromycin and doxycycline on improving patients with COVID-19

Study of the effectiveness of concomitant use of vitamin C, metformin, azithromycin and doxycycline on improving patients with COVID-19

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200418047121N1

Enrollment

Registered

2020-05-01

Start date

2020-05-09

Completion date

Unknown

Last updated

2020-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19. COVID-19, virus identified

Interventions

Intervention 1: The intervention group will receive 250 mg of azithromycin daily for up to five days, 100 mg of doxycycline twice daily, 1.5 g of vitamin C every 6 hours, and 500 mg of metformin daily

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with coronavirus have mild to moderate viral infections diagnosed by an infectious disease specialist

Exclusion criteria

Exclusion criteria: Patients with severe lung involvement and severe respiratory symptoms patients with G6PD deficiency

Design outcomes

Primary

Measure	Time frame
Disease recovery. Timepoint: The beginning of the study and the end of the study. Method of measurement: Based on laboratory and imaging criteria.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Kamran Mansouri

Kermanshah University of Medical Sciences

kamranmansouri@gmail.com+98 83 3427 6473

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026